SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-017293
Filing Date
2024-05-16
Accepted
2024-05-16 16:08:51
Documents
16
Period of Report
2024-05-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cont20240417_8k.htm   iXBRL 8-K 27680
2 EXHIBIT 99.1 ex_675147.htm EX-99.1 73866
7 image1.jpg GRAPHIC 3092
  Complete submission text file 0001437749-24-017293.txt   251646

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA noticker-20240516.xsd EX-101.SCH 3441
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE noticker-20240516_def.xml EX-101.DEF 11816
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE noticker-20240516_lab.xml EX-101.LAB 15848
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE noticker-20240516_pre.xml EX-101.PRE 12031
19 EXTRACTED XBRL INSTANCE DOCUMENT cont20240417_8k_htm.xml XML 2966
Mailing Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 (858) 333-5280
Contineum Therapeutics, Inc. (Filer) CIK: 0001855175 (see all company filings)

IRS No.: 271467257 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42001 | Film No.: 24955582
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)